485 related articles for article (PubMed ID: 32512291)
1. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.
Gommans DHF; Nas J; Pinto-Sietsma SJ; Koop Y; Konst RE; Mensink F; Aarts GWA; Konijnenberg LSF; Cortenbach K; Verhaert DVM; Thannhauser J; Mol JQ; Rooijakkers MJP; Vos JL; van Rumund A; Vart P; Hassing RJ; Cornel JH; de Jager CPC; van den Heuvel MM; van der Hoeven HG; Verbon A; Pinto YM; van Royen N; van Kimmenade RRJ; ; de Leeuw PW; van Agtmael MA; Bresser P; ; van Gilst WH; Vonk-Noordergraaf A; Tijssen JGP; ; van Royen N; de Jager CPC; van den Heuvel MM; van der Hoeven HG; Verbon A; Pinto YM; van Kimmenade RRJ
Am Heart J; 2020 Aug; 226():60-68. PubMed ID: 32512291
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
3. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
4. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
Fragoso-Saavedra S; Iruegas-Nunez DA; Quintero-Villegas A; García-González HB; Nuñez I; Carbajal-Morelos SL; Audelo-Cruz BM; Arias-Martínez S; Caro-Vega Y; Calva JJ; Luqueño-Martínez V; González-Duarte A; Crabtree-Ramírez B; Crispín JC; Sierra-Madero J; Belaunzarán-Zamudio PF; Valdés-Ferrer SI
BMC Infect Dis; 2020 Oct; 20(1):765. PubMed ID: 33066761
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
[TBL] [Abstract][Full Text] [Related]
6. SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure.
Pannu S; Exline MC; Bednash JS; Englert JA; Diaz P; Bartlett A; Brock G; Wu Q; Davis IC; Crouser ED
Trials; 2024 May; 25(1):328. PubMed ID: 38760804
[TBL] [Abstract][Full Text] [Related]
7. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Feldman A; D'Andréa Saba Arruda G; de Souza AS; de Albuquerque DC; Mazza L; Santos MF; Salvador NZ; Gibson CM; Granger CB; Alexander JH; de Souza OF;
Am Heart J; 2020 Aug; 226():49-59. PubMed ID: 32502882
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study.
Matsuzawa Y; Ogawa H; Kimura K; Konishi M; Kirigaya J; Fukui K; Tsukahara K; Shimizu H; Iwabuchi K; Yamada Y; Saka K; Takeuchi I; Hirano T; Tamura K
Hypertens Res; 2020 Nov; 43(11):1257-1266. PubMed ID: 32820236
[TBL] [Abstract][Full Text] [Related]
9. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
Tomazini BM; Maia IS; Cavalcanti AB; Berwanger O; Rosa RG; Veiga VC; Avezum A; Lopes RD; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Damiani LP; Lisboa T; Kawano-Dourado L; Zampieri FG; Olivato GB; Righy C; Amendola CP; Roepke RML; Freitas DHM; Forte DN; Freitas FGR; Fernandes CCF; Melro LMG; Junior GFS; Morais DC; Zung S; Machado FR; Azevedo LCP;
JAMA; 2020 Oct; 324(13):1307-1316. PubMed ID: 32876695
[TBL] [Abstract][Full Text] [Related]
10. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
11. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
[TBL] [Abstract][Full Text] [Related]
12. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Dequin PF; Heming N; Meziani F; Plantefève G; Voiriot G; Badié J; François B; Aubron C; Ricard JD; Ehrmann S; Jouan Y; Guillon A; Leclerc M; Coffre C; Bourgoin H; Lengellé C; Caille-Fénérol C; Tavernier E; Zohar S; Giraudeau B; Annane D; Le Gouge A;
JAMA; 2020 Oct; 324(13):1298-1306. PubMed ID: 32876689
[TBL] [Abstract][Full Text] [Related]
13. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
[TBL] [Abstract][Full Text] [Related]
14. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls.
Gorenstein SA; Castellano ML; Slone ES; Gillette B; Liu H; Alsamarraie C; Jacobson AM; Wall SP; Adhikari S; Swartz JL; McMullen JJS; Osorio M; Koziatek CA; Lee DC
Undersea Hyperb Med; 2020; 47(3):405-413. PubMed ID: 32931666
[TBL] [Abstract][Full Text] [Related]
15. Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.
Nickols NG; Goetz MB; Graber CJ; Bhattacharya D; Soo Hoo G; Might M; Goldstein DB; Wang X; Ramoni R; Myrie K; Tran S; Ghayouri L; Tsai S; Geelhoed M; Makarov D; Becker DJ; Tsay JC; Diamond M; George A; Al-Ajam M; Belligund P; Montgomery RB; Mostaghel EA; Sulpizio C; Mi Z; Dematt E; Tadalan J; Norman LE; Briones D; Clise CE; Taylor ZW; Huminik JR; Biswas K; Rettig MB
Trials; 2021 Jul; 22(1):431. PubMed ID: 34225789
[TBL] [Abstract][Full Text] [Related]
16. Association between obesity and clinical prognosis in patients infected with SARS-CoV-2.
Cai SH; Liao W; Chen SW; Liu LL; Liu SY; Zheng ZD
Infect Dis Poverty; 2020 Jun; 9(1):80. PubMed ID: 32600411
[TBL] [Abstract][Full Text] [Related]
17. Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.
Kocayigit I; Kocayigit H; Yaylaci S; Can Y; Erdem AF; Karabay O
Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):71-76. PubMed ID: 32965360
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.
Chand S; Kapoor S; Orsi D; Fazzari MJ; Tanner TG; Umeh GC; Islam M; Dicpinigaitis PV
J Intensive Care Med; 2020 Oct; 35(10):963-970. PubMed ID: 32812834
[TBL] [Abstract][Full Text] [Related]
19. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.
Atmowihardjo L; Schippers JR; Bartelink IH; Bet PM; van Rein N; Purdy K; Cavalla D; Comberiati V; McElroy A; Snape SD; Bogaard HJ; Heunks L; Juffermans N; Schultz M; Tuinman PR; Bos LDJ; Aman J
Trials; 2022 Feb; 23(1):158. PubMed ID: 35172891
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID).
Malchair P; Otero A; Giol J; Solanich X; Carnaval T; Fernández-Nistal A; Sánchez-Gabriel A; Montoto C; Lleonart R; Videla S;
Trials; 2022 Apr; 23(1):303. PubMed ID: 35413921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
